These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937 [TBL] [Abstract][Full Text] [Related]
48. Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes. Casacuberta-Serra S; Parés M; Golbano A; Coves E; Espejo C; Barquinero J Immunol Cell Biol; 2017 Jul; 95(6):538-548. PubMed ID: 28108746 [TBL] [Abstract][Full Text] [Related]
49. Recent advances in myeloid-derived suppressor cell biology. Yaseen MM; Abuharfeil NM; Darmani H; Daoud A Front Med; 2021 Apr; 15(2):232-251. PubMed ID: 32876877 [TBL] [Abstract][Full Text] [Related]
50. Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders. Barnie PA; Zhang P; Lv H; Wang D; Su X; Su Z; Xu H Exp Ther Med; 2017 Feb; 13(2):378-388. PubMed ID: 28352304 [TBL] [Abstract][Full Text] [Related]
51. Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment. Sceneay J; Griessinger CM; Hoffmann SHL; Wen SW; Wong CSF; Krumeich S; Kneilling M; Pichler BJ; Möller A PLoS One; 2018; 13(4):e0196040. PubMed ID: 29677215 [TBL] [Abstract][Full Text] [Related]
52. SIRT1 and HIF1α signaling in metabolism and immune responses. Yu Q; Dong L; Li Y; Liu G Cancer Lett; 2018 Apr; 418():20-26. PubMed ID: 29306019 [TBL] [Abstract][Full Text] [Related]
53. Distribution and differentiation of myeloid-derived suppressor cells after fluid resuscitation in mice with hemorrhagic shock. Jiang JK; Fang W; Hong LJ; Lu YQ J Zhejiang Univ Sci B; 2017 Jan.; 18(1):48-58. PubMed ID: 28070996 [TBL] [Abstract][Full Text] [Related]
54. Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy. Zhang W; Li J; Qi G; Tu G; Yang C; Xu M J Transl Med; 2018 Jan; 16(1):19. PubMed ID: 29378596 [TBL] [Abstract][Full Text] [Related]
55. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation. Zhang H; Lian M; Zhang J; Bian Z; Tang R; Miao Q; Peng Y; Fang J; You Z; Invernizzi P; Wang Q; Gershwin ME; Ma X Hepatology; 2018 Jan; 67(1):232-246. PubMed ID: 28777871 [TBL] [Abstract][Full Text] [Related]
56. Expansion of myeloid-derived suppressor cells with aging in the bone marrow of mice through a NF-κB-dependent mechanism. Flores RR; Clauson CL; Cho J; Lee BC; McGowan SJ; Baker DJ; Niedernhofer LJ; Robbins PD Aging Cell; 2017 Jun; 16(3):480-487. PubMed ID: 28229533 [TBL] [Abstract][Full Text] [Related]
57. CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice. Foks AC; Van Puijvelde GH; Wolbert J; Kröner MJ; Frodermann V; Van Der Heijden T; Van Santbrink PJ; Boon L; Bot I; Kuiper J Cardiovasc Res; 2016 Aug; 111(3):252-61. PubMed ID: 27234908 [TBL] [Abstract][Full Text] [Related]
58. microRNAs as potential regulators of myeloid-derived suppressor cell expansion. El Gazzar M Innate Immun; 2014 Apr; 20(3):227-38. PubMed ID: 23757323 [TBL] [Abstract][Full Text] [Related]
59. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Cuenca AG; Delano MJ; Kelly-Scumpia KM; Moreno C; Scumpia PO; Laface DM; Heyworth PG; Efron PA; Moldawer LL Mol Med; 2011; 17(3-4):281-92. PubMed ID: 21085745 [TBL] [Abstract][Full Text] [Related]